Nelson KE, Celentano DD, Eiumtrakol S, Hoover DR, Beyrer C, Suprasert S, Kuntolbutra S, Khamboonruang C. 1996. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. New England Journal of Medicine 335(5):297–303.

Ngugi EN, Plummer FA, Simonsen JN, Cameron DW, Bosire M, Waiyaki P, Ronald AR, Ndinya-Achola JO. 1988. Prevention of transmission of human immunodeficiency virus in Africa: effectiveness of condom promotion and health education among prostitutes. Lancet 2(8616):887–890.

Pinkerton SD and Holtgrave DR. 1998. The cost-effectiveness of HIV prevention from a managed care perspective. Journal of Public Health Management and Practice 4(1):59–66.

Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH. 2000. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England Journal of Medicine 342(13):921–929.

Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. 1993. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry 50(2):85–94.

Rotheram-Borus MJ, Gillis JR, Reid HM, Fernandez MI, Gwadz M. 1997. HIV testing, behaviors, and knowledge among adolescents at high risk. Journal of Adolescent Health 20(3):216–225.

Schulz RM, Mullenix TA, Googe HL, Grant D, Duong PT, Ortiz E. 1998. Depression scores and antiretroviral therapy adherence in HIV disease (Abstract I-215). Interscience Conference on Antimicrobial Agents and Chemotherapy; Sep 24–27, 1998; San Diego.

Shoptaw S, Reback CJ, Frosch DL, Rawson RA. 1998. Stimulant abuse treatment as HIV prevention. Journal of Addictive Diseases 17(4):19–32.

Sikkema KJ, Kelly JA, Winett RA, Solomon LJ, Cargill VA, Roffman RA, McAuliffe TL, Heckman TG, Anderson EA, Wagstaff DA, Norman AD, Perry MJ, Crumble DA, Mercer MB. 2000. Outcomes of a randomized community-level HIV prevention intervention for women living in 18 low-income housing developments. American Journal of Public Health 90(1):57–63.

St. Lawrence JS, Brasfield TL, Jefferson KW, Alleyne E, O’Bannon RE 3rd, Shirley A. 1995. Cognitive-behavioral intervention to reduce African American adolescents’ risk for HIV infection. Journal of Consulting and Clinical Psychology 63(2):221–237.

Stanton BF, Li X, Ricardo I, Galbraith J, Feigelman S, Kaljee L. 1996. A randomized, controlled effectiveness trial of an AIDS prevention program for low-income African-American youths. Archives of Pediatric and Adolescent Medicine 150(4):363–372.

U.S. Conference of Mayors. 1994. CDC’s Prevention Marketing Initiative: A Multi-level Approach to HIV Prevention. HIV Capsule Report, Issue 2. Washington, DC: U.S. Conference of Mayors.

Valdiserri RO, Lyter DW, Leviton LC, Callahan CM, Kingsley LA, Rinaldo CR. 1989. AIDS prevention in homosexual and bisexual men: Results of a randomized trial evaluating two risk reduction interventions. AIDS 3(1):21–26.

Valleroy LA, Weinstein B, Jones TS, Groseclose SL, Rolfs RT, Kassler WJ. 1995. Impact of increased legal access to needles and syringes on community pharmacies’ needle and syringe sales—Connecticut, 1992. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10(1):73–81.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement